![Pat O’Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Pat O’Sullivan worked at Genzyme Therapeutics Ltd. from 2001 to 2022 as Vice President-Global Supply Chain.
From 2022 to 2026, Mr. O’Sullivan worked at Amicus Therapeutics, Inc. as Chief Technical Operations Officer.
Mr. O’Sullivan completed an MBA at The Open University and an undergraduate degree at Munster Technological University.
Precedenti posizioni note di Pat O’Sullivan
| Società | Posizione | Fine |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Direttore operativo | 27/04/2026 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01/08/2022 |
Formazione di Pat O’Sullivan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
28
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Munster Technological University
 Munster Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
